Table 1.
Demographic characteristics of the study population
| Number | |
|---|---|
| Sex | |
| Male | 79 |
| Female | 6 |
| Age | |
| Range | 31–78 |
| Median | 56 |
| <60 | 57 |
| ≥60 | 28 |
| ECOG PS | |
| 0–1 | 54 |
| 2 | 31 |
| Initial disease status | |
| Metastatic | 65 |
| Relapsed | 20 |
| Metastatic sites | |
| Lymph node | 25 |
| Lung | 20 |
| Liver | 20 |
| Bone | 12 |
| Others | 8 |
| Response to first-line treatment | |
| CR + PR | 40 |
| SD + PD | 45 |
| Chemotherapy regimen | |
| Docetaxel-platinum | 44 |
| Docetaxel | 41 |
Abbreviations: CR, complete response; ECOG PS, the Eastern Cooperative Oncology Group scale of Performance Status; PD, progressive disease; PR, partial response; SD, stable disease.